Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction

American Journal of Kidney Diseases

Volumn 37, Issue 6, 2001, Pages 1191-1200

  Beattie, John N ^a,b   Soman, Sandeep S ^a,b   Sandberg, Keisha R ^a,b   Yee, Jerry ^a,b   Borzak, Steven ^a,b   Garg, Mukesh ^a,b   McCullough, Peter A ^a,b  

^a HENRY FORD HOSPITAL   (United States)

^b TRUMAN MEDICAL CENTER   (United States)

Author keywords

Arrhythmias; Complications; Coronary care unit; Renal failure; Survival

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; FIBRINOLYTIC AGENT;

ADULT; AGE; AGED; ARTICLE; ASYSTOLE; CARDIOGENIC SHOCK; CORONARY ARTERY DISEASE; CORONARY CARE UNIT; CREATININE CLEARANCE; DIABETES MELLITUS; DIALYSIS; FEMALE; HEART ATRIUM ARRHYTHMIA; HEART BLOCK; HEART FAILURE; HEART INFARCTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERTENSION; KIDNEY FAILURE; LUNG CONGESTION; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MORTALITY; NEGRO; PROSPECTIVE STUDY; REGISTER; ST SEGMENT ELEVATION;

EID: 0035003726     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2001.24522     Document Type: Article

References (41)

1. Survival after acute myocardial infarction in patients with end-stage renal disease: Results from the Cooperative Cardiovascular Project
2. Long-term survival of renal transplant recipients in the United States after acute myocardial infarction
3. Renal dysfunction after myocardial revascularization: Risk factors, adverse outcomes, and hospital resource utilization
4. Aspects of cardiovascular burden in predialysis patients
5. Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality
6. Preoperative renal risk stratification
7. Serum creatinine concentration and risk of cardiovascular disease: A possible marker for increased risk of stroke
8. Risk factors for abdominal aortic aneurysms in older adults enrolled in The Cardiovascular Health Study
9. The Henry Ford Health System
10. Henry Ford Health System medical information management system: Strategy for creating a community-wide health information system
11. Risks associated with renal dysfunction in coronary care unit patients
12. Prediction of creatinine clearance from serum creatinine
13. Predictability of creatinine clearance estimates in critically ill patients
14. Geriatric renal function: Estimating glomerular filtration in an ambulatory elderly population
15. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation
16. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction
17. Significance of left ventricular hypertrophy in cardiovascular morbidity and mortality
18. Cardiovascular disease risk profiles
19. Serum total homocysteine and coronary heart disease
20. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes
21. Validity of electrocardiographic estimates of left ventricular hypertrophy and mass in African Americans (The Charleston Heart Study)
22. Relation between electrocardiography and echocardiography for left ventricular mass in mild systemic hypertension (results from Treatment of Mild Hypertension Study)
23. The reliability and validity of echocardiographic measurement of left ventricular mass index in hemodialysis patients
24. Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention
25. Incidence, outcome, and risk factors of cerebrovascular events in patients undergoing maintenance hemodialysis
26. The clinical course of left ventricular hypertrophy in dialysis patients
27. Left ventricular hypertrophy as a risk factor for arrhythmias in hemodialysis patients
28. Multicentre, cross-sectional study of ventricular arrhythmias in chronically haemodialysed patients
29. Comparison of echocardiographic changes associated with hemodialysis and renal transplantation
30. Course of left ventricular diastolic dysfunction in end-stage renal disease on long-term continuous ambulatory peritoneal dialysis
31. Differential expression of renal nitric oxide synthase isoforms during pregnancy in rats
32. The renin-angiotensin system in diabetic nephropathy: The endothelial connection
33. Hyperhomocysteinemia and the risk for vascular disease in hemodialysis patients
34. Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study
35. Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations
36. Plasma homocysteine levels and mortality in patients with coronary artery disease
37. Serum homocysteine concentration as an indicator of survival in patients with acute coronary syndromes
38. Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein(a) excess in maintenance dialysis patients: A matched case-control study
39. Alterations in nonenzymatic biochemistry in uremia: Origin and significance of "carbonyl stress" in long-term uremic complications
40. Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here?
41. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis